--- schema_version: "secwatch.filing_event.v1" accession: "0001193125-23-001161" form_type: "8-K" ticker: "GEHC" cik: "0001932393" company_name: "GE HealthCare Technologies Inc." filed_at: "2023-01-04T23:59:59+00:00" generated_at: "2026-06-20T20:30:50.300091+00:00" event_type: "other_material" sentiment: "neutral" materiality_score: 0.7 calibrated_materiality_score: 0.7 confidence: "high" source: SEC EDGAR --- # GE HealthCare completes spin-off from GE; becomes independent public company ## Summary - GE distributed 80.1% of GEHC common stock to GE holders on Jan 3, 2023, at ratio of 1 share per 3 GE shares held. - Drew full $2.0B under 3-year senior unsecured term loan facility entered Nov 2022. - Board of 9 directors appointed; Catherine Lesjak chairs Audit, William Stromberg chairs Talent/Comp. - Non-employee directors receive $125k annual cash retainer and $200k RSU grant per year. ## SEC filing metadata - accession: 0001193125-23-001161 - form_type: 8-K - ticker: GEHC - cik: 0001932393 - company_name: GE HealthCare Technologies Inc. - filed_at: 2023-01-04T23:59:59+00:00 - event_type: other_material - sentiment: neutral - materiality_score: 0.7 - calibrated_materiality_score: 0.7 - confidence: high - sec_items: 1.01, 2.03, 5.01, 5.02, 8.01, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/d386556d8k.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001193125-23-001161 - JSON: https://secwatch.observer/filing/0001193125-23-001161.json - Plain text: https://secwatch.observer/filing/0001193125-23-001161.txt ## Key facts - Debt Financings GE HealthCare Technologies Inc. incurred term loan of $2.0 billion. - Instrument: term loan - Principal: $2.0 billion - Event: incurrence source text: On the Distribution Date, we drew down the full $2.0 billion available under the Term Loan Agreement. evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Tomislav Mihaljevic was appointed as Director at GE HealthCare Technologies Inc.. - Action: appointed - Role: Director source text: Tomislav Mihaljevic 58 Talent, Culture, and Compensation Committee and Nominating and Governance Committee evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Phoebe L. Yang was appointed as Director at GE HealthCare Technologies Inc.. - Action: appointed - Role: Director source text: Phoebe L. Yang 53 Talent, Culture, and Compensation Committee and Nominating and Governance Committee evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Peter J. Arduini was appointed as Director at GE HealthCare Technologies Inc.. - Action: appointed - Role: Director source text: Peter J. Arduini 58 None evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Lloyd W. Howell, Jr. was appointed as Director at GE HealthCare Technologies Inc.. - Action: appointed - Role: Director source text: Lloyd W. Howell, Jr. 56 Audit Committee and Talent, Culture, and Compensation Committee evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change H. Lawrence Culp, Jr. was appointed as Director at GE HealthCare Technologies Inc.. - Action: appointed - Role: Director source text: H. Lawrence Culp, Jr. 59 None evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Jan Makela was appointed as CEO, Imaging at GE HealthCare Technologies Inc.. - Action: appointed - Role: CEO, Imaging source text: Jan Makela 54 CEO, Imaging evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Risa Lavizzo-Mourey was appointed as Director at GE HealthCare Technologies Inc.. - Action: appointed - Role: Director source text: Risa Lavizzo-Mourey 68 Nominating and Governance Committee (Chair) evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Frank R. Jimenez was appointed as General Counsel and Corporate Secretary at GE HealthCare Technologies Inc.. - Action: appointed - Role: General Counsel and Corporate Secretary source text: Frank R. Jimenez 57 General Counsel and Corporate Secretary evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change William J. Stromberg was appointed as Director at GE HealthCare Technologies Inc.. - Action: appointed - Role: Director source text: William J. Stromberg 62 Audit Committee and Talent, Culture, and Compensation Committee (Chair) evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change George A. Newcomb was appointed as Chief Accounting Officer at GE HealthCare Technologies Inc.. - Action: appointed - Role: Chief Accounting Officer source text: George A. Newcomb 55 Chief Accounting Officer evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Anne T. Madden was appointed as Director at GE HealthCare Technologies Inc.. - Action: appointed - Role: Director source text: Anne T. Madden 58 Audit Committee and Nominating and Governance Committee evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Helmut Zodl was appointed as Chief Financial Officer at GE HealthCare Technologies Inc.. - Action: appointed - Role: Chief Financial Officer source text: Helmut Zodl 50 Chief Financial Officer evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Betty D. Larson was appointed as Chief People Officer at GE HealthCare Technologies Inc.. - Action: appointed - Role: Chief People Officer source text: Betty D. Larson 46 Chief People Officer evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Catherine Lesjak was appointed as Director at GE HealthCare Technologies Inc.. - Action: appointed - Role: Director source text: Catherine Lesjak 63 Audit Committee (Chair) evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Rodney F. Hochman was appointed as Director at GE HealthCare Technologies Inc.. - Action: appointed - Role: Director source text: Rodney F. Hochman 67 Audit Committee and Nominating and Governance Committee evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Roland Rott was appointed as CEO, U at GE HealthCare Technologies Inc.. - Action: appointed - Role: CEO, U source text: Roland Rott 51 CEO, U evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Peter J. Arduini was appointed as President, Chief Executive Officer, and Director at GE HealthCare Technologies Inc.. - Action: appointed - Role: President, Chief Executive Officer, and Director source text: Peter J. Arduini 58 President, Chief Executive Officer, and Director evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Executive change Kevin M. O’Neill was appointed as CEO, Pharmaceutical Diagnostics at GE HealthCare Technologies Inc.. - Action: appointed - Role: CEO, Pharmaceutical Diagnostics source text: Kevin M. O’Neill 54 CEO, Pharmaceutical Diagnostics evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - M&A Transactions GE HealthCare Technologies Inc. completed a disposition involving General Electric Company (closed 2023-01-03). - Action: disposition - Counterparty: General Electric Company - Closing: 2023-01-03 source text: On January 3, 2023 (the “Distribution Date”), General Electric Company (“GE”) completed the previously announced distribution of approximately 80.1% of the shares of the common stock of GE HealthCare Technologies Inc. (“GE HealthCare,” the “Company,” “we,” “us,” or “our”) by GE to holders of GE common stock on a pro rata basis (the “Spin-Off”). evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Material Agreements GE HealthCare Technologies Inc. entered into Transition Services Agreement with GE (effective 2023-01-03). - Action: entry - Counterparty: GE - Effective: 2023-01-03 source text: if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On January 3, 2023 (the “Distribution Date”), General Electric Company (“GE”) completed the previously announced distribution of approximately 80.1% of the shares of the common stock of GE HealthCare Technologies Inc. evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Material Agreements GE HealthCare Technologies Inc. entered into Separation and Distribution Agreement with GE (effective 2023-01-03). - Action: entry - Agreement: supply - Counterparty: GE - Effective: 2023-01-03 source text: if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On January 3, 2023 (the “Distribution Date”), General Electric Company (“GE”) completed the previously announced distribution of approximately 80.1% of the shares of the common stock of GE HealthCare Technologies Inc. evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Material Agreements GE HealthCare Technologies Inc. entered into Trademark License Agreement with GE (effective 2023-01-03). - Action: entry - Agreement: license - Counterparty: GE - Effective: 2023-01-03 source text: if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On January 3, 2023 (the “Distribution Date”), General Electric Company (“GE”) completed the previously announced distribution of approximately 80.1% of the shares of the common stock of GE HealthCare Technologies Inc. evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Material Agreements GE HealthCare Technologies Inc. entered into Employee Matters Agreement with GE (effective 2023-01-03). - Action: entry - Counterparty: GE - Effective: 2023-01-03 source text: if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On January 3, 2023 (the “Distribution Date”), General Electric Company (“GE”) completed the previously announced distribution of approximately 80.1% of the shares of the common stock of GE HealthCare Technologies Inc. evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm - Material Agreements GE HealthCare Technologies Inc. entered into Tax Matters Agreement with GE (effective 2023-01-03). - Action: entry - Counterparty: GE - Effective: 2023-01-03 source text: if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01 Entry into a Material Definitive Agreement. On January 3, 2023 (the “Distribution Date”), General Electric Company (“GE”) completed the previously announced distribution of approximately 80.1% of the shares of the common stock of GE HealthCare Technologies Inc. evidence_url: https://www.sec.gov/Archives/edgar/data/1932393/000119312523001161/0001193125-23-001161-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.